BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

Laurion Capital Management LP's Holding History (CIK: 0001390202)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 19,100,000 Value ($000) $21,508 Avg Close — Range —
Q3 2025
Shares 19,100,000 Value ($000) $18,875 Avg Close — Range —
Q2 2025
Shares 19,100,000 Value ($000) $17,863 Avg Close — Range —
Q1 2025
Shares 19,100,000 Value ($000) $17,209 Avg Close — Range —
Q4 2024
Shares 19,100,000 Value ($000) $16,364 Avg Close — Range —
Q3 2024
Shares 19,100,000 Value ($000) $15,944 Avg Close — Range —
Q2 2024
Shares 19,100,000 Value ($000) $15,400 Avg Close — Range —
Q1 2024
Shares 19,100,000 Value ($000) $15,730 Avg Close — Range —
Q4 2023
Shares 19,100,000 Value ($000) $16,110 Avg Close — Range —
Q3 2023
Shares 19,100,000 Value ($000) $14,494 Avg Close — Range —
Q2 2023
Shares 19,100,000 Value ($000) $11,772 Avg Close — Range —